Share Twitter LinkedIn Facebook Email W. Kimryn Rathmell, MD, PhD of Vanderbilt Ingram Cancer Center discusses Novel epigenetic targeting approaches at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia